Plasma, tissue, and red blood cell binding studies to determine unbound fraction and support exposure assessment, species comparison, and pharmacokinetic modeling in preclinical drug development.
Plasma, tissue, and red blood cell binding studies to determine unbound fraction and support exposure assessment, species comparison, and pharmacokinetic modeling in preclinical drug development.